GE Healthcare Technologies Inc
GEHC72.860USD
+0.609+0.84%
Fechamento 06/16, 16:00（ET）Cotações atrasadas em 15 min
33.36BValor de mercado
16.74P/L TTM
Mais detalhes de GE Healthcare Technologies Inc Empresa
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Informações da empresa
Código da empresaGEHC
Nome da EmpresaGE Healthcare Technologies Inc
Data de listagemDec 15, 2022
Fundado em2022
CEOMr. Kevin Michael O'Neill
Número de funcionários53000
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 15
Endereço500 West Monroe Street
CidadeCHICAGO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal60661
Telefone18337351139
Sitehttps://www.gehealthcare.com
Código da empresaGEHC
Data de listagemDec 15, 2022
Fundado em2022
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
+55.32%
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
+43.77%
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
+51.33%
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
Por RegiãoUSD
Nome
Receita
Proporção
Other
8.92B
45.34%
United States
8.62B
43.80%
China
2.13B
10.85%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.18%
BlackRock Institutional Trust Company, N.A.
5.52%
Capital Research Global Investors
4.80%
State Street Global Advisors (US)
4.21%
Dodge & Cox
3.62%
Other
70.67%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.18%
BlackRock Institutional Trust Company, N.A.
5.52%
Capital Research Global Investors
4.80%
State Street Global Advisors (US)
4.21%
Dodge & Cox
3.62%
Other
70.67%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
36.36%
Investment Advisor
31.92%
Hedge Fund
4.48%
Pension Fund
2.38%
Research Firm
2.32%
Sovereign Wealth Fund
1.43%
Bank and Trust
1.36%
Insurance Company
0.39%
Individual Investor
0.28%
Other
19.09%
Participação acionária institucional
Atualizado em: dom, 19 de jan
Atualizado em: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
2382
403.84M
88.19%
-15.58M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
2023Q1
1358
378.91M
83.35%
+182.70M
2022Q4
41
468.43M
103.20%
+468.43M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
52.34M
11.45%
+2.16M
+4.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
24.86M
5.44%
+239.16K
+0.97%
Dec 31, 2024
Capital Research Global Investors
60.83M
13.3%
+2.61M
+4.48%
Dec 31, 2024
State Street Global Advisors (US)
18.90M
4.13%
+281.45K
+1.51%
Dec 31, 2024
Dodge & Cox
16.68M
3.65%
+11.87K
+0.07%
Dec 31, 2024
Geode Capital Management, L.L.C.
11.32M
2.48%
+342.82K
+3.12%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
9.45M
2.07%
+126.88K
+1.36%
Feb 28, 2025
Norges Bank Investment Management (NBIM)
6.25M
1.37%
+1.84M
+41.76%
Dec 31, 2024
AllianceBernstein L.P.
6.13M
1.34%
-220.13K
-3.47%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
Langar Global HealthTech ETF
10.51%
Invesco S&P Spin-Off ETF
8.01%
Global X HealthTech ETF
4.26%
iShares U.S. Medical Devices ETF
3.77%
Absolute Select Value ETF
3.36%
VanEck Morningstar Wide Moat Value ETF
2.51%
Capital Group Dividend Value ETF
2.37%
VanEck Morningstar Wide Moat ETF
2.22%
First Trust Indxx Medical Devices ETF
2.11%
Themes US R&D Champions ETF
1.79%
Ver Mais
Langar Global HealthTech ETF
Proporção10.51%
Invesco S&P Spin-Off ETF
Proporção8.01%
Global X HealthTech ETF
Proporção4.26%
iShares U.S. Medical Devices ETF
Proporção3.77%
Absolute Select Value ETF
Proporção3.36%
VanEck Morningstar Wide Moat Value ETF
Proporção2.51%
Capital Group Dividend Value ETF
Proporção2.37%
VanEck Morningstar Wide Moat ETF
Proporção2.22%
First Trust Indxx Medical Devices ETF
Proporção2.11%
Themes US R&D Champions ETF
Proporção1.79%
Dividendo
Um total de
96.00M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
